Vancouver biotech anchor AbCellera has broken ground at the Mount Pleasant address that will soon be home to Phase 2 of the Vancouver-grown company’s 380,000-square-foot global headquarters. AbCellera’s leadership team were joined by members of the local biotech ecosystem to celebrate the future, world-class biotech campus that will employ hundreds of highly skilled technical personnel. […]
AbCellera
AbCellera-Discovered Antibody Receives FDA Emergency Use Authorization
AbCellera‘s second antibody developed through AbCellera’s collaboration with Eli Lilly, bebtelovimab (LY-CoV1404), has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). Bebtelovimab is authorized for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for […]
BC Tech Announces Winners of 2021 Technology Impact Awards
Now in their 28th year, the Technology Impact Awards (TIAs) have never had more reasons to celebrate than they did last night at Science World. The sold-out TIAs Gala returned to an in-person format while also broadcasting the event live to the tech community. “It was wonderful to come together as a community and experience […]
18 B.C. Tech Companies Named Deloitte Technology Fast 50 Winners
Deloitte Canada has announced this year’s winners of the Technology Fast 50, Companies-to-Watch, and Enterprise Fast 15 awards, recognizing the world-class achievements of the best in tech companies across Canada for the 24th year. 2021 saw its own unique challenges that shaped today’s tech companies. The list unveiled today highlights those who have shown true […]
AbCellera Acquires TetraGenetics, Enhancing Capabilities to Generate Antibodies Against High-Value Targets
Vancouver’s AbCellera has acquired Boston’s TetraGenetics, a biotech company with a proprietary platform for generating recombinant human ion channels and other transmembrane proteins. The acquisition was an all-cash transaction one that includes an upfront payment, the potential for payments based on the achievement of technical milestones, and additional development and commercial milestone payments related to […]
Life Sciences BC Announces Annual Award Winners
British Columbia has a vibrant and thriving life sciences industry that is distinguished not only by local and national accomplishments, but also by international recognition. Life Sciences BC has announced the recipients of the 23rd Annual Life Sciences BC Awards which recognize the talented individuals and organizations who contribute to the vibrant life sciences ecosystem […]
Connecting The Dots: July 2021
Each month, Kathleen Reid (Founder + Managing Director at Switchboard Public Relations) connects the dots between the trends, headlines and narratives that are informing the BC tech sector. Following a two-month hiatus, she resumes CTD’s regular monthly schedule by shedding light on BC Tech’s New Economy Report, recent acquisitions by BC’s biggest tech companies, and […]
Canada Highlights Support For Innovation In British Columbia
As Canadians begin to look toward economic recovery, Canada’s small and medium-sized enterprises (SME) will be the backbone of economic growth in communities across the country. These firms are already supporting more than 10 million jobs for Canadian workers, and many of them are making groundbreaking discoveries to improve Canadians’ lives and drive innovation and technology. To […]
AbCellera To Build Manufacturing Facility Within Walking Distance Of New HQ
AbCellera has secured a site in Vancouver for the construction of a Good Manufacturing Practices (GMP) manufacturing facility for the production of therapeutic antibodies, which will be the first of its kind in Canada. The 130,000-square-foot facility will expand AbCellera’s capabilities in bringing new antibody therapies to clinical trials, supporting Canada’s efforts to respond quickly […]
AbCellera Breaks Ground on Global Headquarters in Vancouver
Vancouver’s AbCellera announced today that it has broken ground on an expanded global headquarters in Vancouver in anticipation of adding hundreds of employees to its current 250-person workforce over the next few years. “We’re building state-of-the-art facilities in Vancouver to accelerate the development of new antibody therapies with biotech and pharma partners from around the world,” […]